» Articles » PMID: 35928664

Comparison of Efficacy and Safety of Transdermal Buprenorphine Patch and Conventional Analgesics in Intra-capsular Femur Neck Fracture Post Hemiarthroplasty

Overview
Journal Indian J Orthop
Publisher Springer Nature
Specialty Orthopedics
Date 2022 Aug 5
PMID 35928664
Authors
Affiliations
Soon will be listed here.
Abstract

Background: One of the most common fractures in the elderly population is a fracture of the neck of femur. Effective post-operative analgesia is a major challenge. Age-related co-morbidities restrict the choice of analgesics. The purpose of this study was to compare the efficacy and safety of transdermal buprenorphine [TDB] patch and conventional analgesics following hemiarthroplasty for intra-capsular fracture neck of femur.

Materials And Methods: This was a prospective, randomized control study done in 60 patients undergoing hemiarthroplasty for intra-capsular fracture neck of femur over a period of 2 years. Patients were randomized in 2 groups. Group A received a combination of IV paracetamol and tramadol for first 48 h followed by oral formulation. In Group B patients, a transdermal buprenorphine patch of 5 mcg/h was applied at the beginning of surgery and was continued 2 weeks post-operative.Pain score by VAS was observed both at rest and on movement and followed up till 14 days post-operative. Primary target was to maintain a VAS ≤ 4. Rescue analgesic was given if the VAS was ≥ 6. Secondary targets were number of rescue analgesics required, adverse reactions and complications if any.

Results: Group B had significantly lower pain scores at rest and during movement [ value 0.0012 to ≤ 0.0001], so was rescue analgesia requirement. No significant side effects were seen in TDB group.

Conclusion: TDB patch is safe and provides superior analgesia and compliance as compared to conventional analgesics in the post-operative period in proximal femur fracture surgeries.

Citing Articles

Comments on: Buprenorphine for acute pain in older adults: a systematic review with meta-analysis.

Larach D Pain Med. 2024; 26(2):124-125.

PMID: 39418207 PMC: 11789778. DOI: 10.1093/pm/pnae106.

References
1.
Pergolizzi Jr J, Scholten W, Smith K, Leighton-Scott J, Willis J, Henningfield J . The unique role of transdermal buprenorphine in the global chronic pain epidemic. Acta Anaesthesiol Taiwan. 2015; 53(2):71-6. DOI: 10.1016/j.aat.2015.06.001. View

2.
Griffiths R, Alper J, Beckingsale A, Goldhill D, Heyburn G, Holloway J . Management of proximal femoral fractures 2011: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2011; 67(1):85-98. DOI: 10.1111/j.1365-2044.2011.06957.x. View

3.
Arshad Z, Prakash R, Gautam S, Kumar S . Comparison between Transdermal Buprenorphine and Transdermal Fentanyl for Postoperative Pain Relief after Major Abdominal Surgeries. J Clin Diagn Res. 2016; 9(12):UC01-4. PMC: 4717684. DOI: 10.7860/JCDR/2015/16327.6917. View

4.
Al-Tawil N, Odar-Cederlof I, Berggren A, Johnson H, Persson J . Pharmacokinetics of transdermal buprenorphine patch in the elderly. Eur J Clin Pharmacol. 2012; 69(2):143-9. PMC: 3548110. DOI: 10.1007/s00228-012-1320-8. View

5.
Desai S, Badiger S, Tokur S, Naik P . Safety and efficacy of transdermal buprenorphine versus oral tramadol for the treatment of post-operative pain following surgery for fracture neck of femur: A prospective, randomised clinical study. Indian J Anaesth. 2017; 61(3):225-229. PMC: 5372402. DOI: 10.4103/ija.IJA_208_16. View